| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |